 PLEASANTON, Calif., Oct. 14, 2021 GLOBE NEWSWIRE -- Natus Medical Incorporated NASDAQ: NTUS, the Company or Natus, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Companys Board of Directors established an Environmental, Social, and Governance ESG committee and transitioned the role of the Quality Compliance Committee to the Innovation Quality committee on September 30th, 2021. 